Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics

Medicine and Dentistry

• Diagnosis 100%
• Pathology 83%
• Neoplasm 50%
• Rare Tumor 50%
• Patient 33%
• Assay 33%
• Tissues 33%
• Molecular Diagnostics 33%
• Biological Marker 33%
• Molecular Pathology 33%
• Methylation 33%
• Medulloblastoma 33%
• RNA Sequencing 33%
• Assessment 16%
• Experience 16%
• DNA Methylation 16%
• Patient Referral 16%
• Consensus 16%
• Formaldehyde 16%
• Immunohistochemistry 16%
• Clinical Research 16%
• Clinical Management 16%
• Biomaterials 16%
• Pathologist 16%
• Fluorescence in Situ Hybridization 16%